Autopsy report · NCT00030693

Vaccine Therapy in Treating Patients With Metastatic Solid Tumors

“Administratively complete.”

The sponsor’s own words in the registry.

Life of this trial

• Registered 2 months after it had already started.
• 42 participants enrolled.
• No results are posted on the registry.

Vital statistics

Status

Terminated

Phase

Phase 1

Sponsor

National Cancer Institute (NCI)

Sponsor type

US National Institutes of Health

Conditions

Unspecified Adult Solid Tumor, Protocol Specific

Interventions

recombinant fowlpox-B7.1 vaccine; recombinant fowlpox-TRICOM vaccine; laboratory biomarker analysis; quality-of-life assessment

Participants

42

Sites

1

Countries

United States

Look deeper

• The official registry record (the source of truth)
• Record history: every change the sponsor made
• Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.